Clinical Trials
79 trialsFeasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer
Canadian Cancer Trials Group
VESICOL
Institut de Cancérologie de Lorraine
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut fĂĽr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Washington University School of Medicine
TEP-Curie
Centre Oscar Lambret
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
NELCER
Tata Memorial Hospital
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Thomas Jefferson University
KEYNOTE-A18
Merck Sharp & Dohme LLC
Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
National Cancer Institute (NCI)
Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
Thomas Jefferson University
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
SBRT
Mayo Clinic
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
IP4-CHRONOS
Imperial College London
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet
Memorial Sloan Kettering Cancer Center
CALLA
AstraZeneca
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
Children's Oncology Group
J-POPS
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Feasibility Study for Ultrasound-Guided Interstitial Brachytherapy for Gynecological CancersV2
Western University, Canada
AMIGO
Dana-Farber Cancer Institute
Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
GOG Foundation
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
Radiation Therapy Oncology Group
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
NSABP Foundation Inc
PORTEC-2
Leiden University Medical Center
FEMINICOL
Institut Claudius Regaud
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Xoft, Inc.
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds
New York Presbyterian Brooklyn Methodist Hospital
Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer
National Cancer Institute (NCI)
Post Market Study Using the Xoft Axxent System
Xoft, Inc.
Partial Breast Radiation Therapy in Treating Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer
Abramson Cancer Center at Penn Medicine
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
Mayo Clinic
DEPICT
Barts & The London NHS Trust
Combination Chemotherapy in Treating Patients With Sarcoma
Mayo Clinic
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
National Cancer Institute (NCI)
BOOST-CA
Institut Paoli-Calmettes
Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer
Masonic Cancer Center, University of Minnesota
Internal Radiation Therapy in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
GOG Foundation
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
University of Miami
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
Alliance for Clinical Trials in Oncology
HPV-RX
Gustave Roussy, Cancer Campus, Grand Paris
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
University of Pittsburgh
Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer
Case Comprehensive Cancer Center